These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 33382428)
1. Pitfalls in RET Fusion Detection Using Break-Apart FISH Probes in Papillary Thyroid Carcinoma. Liu Y; Wu S; Zhou L; Guo Y; Zeng X J Clin Endocrinol Metab; 2021 Mar; 106(4):1129-1138. PubMed ID: 33382428 [TBL] [Abstract][Full Text] [Related]
2. An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma. Zhang T; Lu Y; Ye Q; Zhang M; Zheng L; Yin X; Gavine P; Sun Z; Ji Q; Zhu G; Su X Genes Chromosomes Cancer; 2015 Mar; 54(3):168-76. PubMed ID: 25407564 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Features of Wang Z; Yao Q; Bao L; Chang H; Ren M; Xue T; Wei R; Yu C; Wang Q; Wang Y; Ping B; Bai Q; Zhou X; Zhu X Thyroid; 2024 Oct; 34(10):1260-1270. PubMed ID: 39212716 [No Abstract] [Full Text] [Related]
4. Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements. Colato C; Vicentini C; Cantara S; Pedron S; Brazzarola P; Marchetti I; Di Coscio G; Chilosi M; Brunelli M; Pacini F; Ferdeghini M Eur J Endocrinol; 2015 May; 172(5):571-82. PubMed ID: 25698220 [TBL] [Abstract][Full Text] [Related]
5. Molecular and Cytogenetic Features of NTRK Fusions Enriched in BRAF and RET Double-Negative Papillary Thyroid Cancer. Wu S; Liu Y; Li K; Liang Z; Zeng X J Mol Diagn; 2023 Aug; 25(8):569-582. PubMed ID: 37236546 [TBL] [Abstract][Full Text] [Related]
6. Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis. Musholt TJ; Staubitz JI; Antonio Cámara RJ; Musholt PB; Humberg D; Springer E; Schad A Eur J Surg Oncol; 2019 Jun; 45(6):1018-1024. PubMed ID: 30472213 [TBL] [Abstract][Full Text] [Related]
7. A Performance Comparison of Commonly Used Assays to Detect RET Fusions. Yang SR; Aypar U; Rosen EY; Mata DA; Benayed R; Mullaney K; Jayakumaran G; Zhang Y; Frosina D; Drilon A; Ladanyi M; Jungbluth AA; Rekhtman N; Hechtman JF Clin Cancer Res; 2021 Mar; 27(5):1316-1328. PubMed ID: 33272981 [TBL] [Abstract][Full Text] [Related]
9. Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer. Chen M; Xue J; Sang Y; Jiang W; He W; Hong S; Lv W; Xiao H; Liu R BMC Cancer; 2023 Apr; 23(1):363. PubMed ID: 37081420 [TBL] [Abstract][Full Text] [Related]
10. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct? Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284 [TBL] [Abstract][Full Text] [Related]
11. A novel RET/PTC variant detected in a pediatric patient with papillary thyroid cancer without ionization history. Halkova T; Dvorakova S; Vaclavikova E; Sykorova V; Vcelak J; Sykorova P; Vlcek P; Reboun M; Katra R; Kodetova D; Schrumpf M; van Wezel T; Morreau H; Bendlova B Hum Pathol; 2015 Dec; 46(12):1962-9. PubMed ID: 26472164 [TBL] [Abstract][Full Text] [Related]
12. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937 [TBL] [Abstract][Full Text] [Related]
13. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing. Lee YC; Chen JY; Huang CJ; Chen HS; Yang AH; Hang JF Endocr Pathol; 2020 Dec; 31(4):348-358. PubMed ID: 32880785 [TBL] [Abstract][Full Text] [Related]
14. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases. Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065 [TBL] [Abstract][Full Text] [Related]
15. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications. Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156 [TBL] [Abstract][Full Text] [Related]
16. Novel rearrangements involving the RET gene in papillary thyroid carcinoma. Staubitz JI; Schad A; Springer E; Rajalingam K; Lang H; Roth W; Hartmann N; Musholt TJ Cancer Genet; 2019 Jan; 230():13-20. PubMed ID: 30466862 [TBL] [Abstract][Full Text] [Related]
17. Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view. Caria P; Dettori T; Frau DV; Borghero A; Cappai A; Riola A; Lai ML; Boi F; Calò P; Nicolosi A; Mariotti S; Vanni R Endocr Relat Cancer; 2013 Aug; 20(4):527-36. PubMed ID: 23722226 [TBL] [Abstract][Full Text] [Related]
18. ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma. Staubitz JI; Musholt TJ; Schad A; Springer E; Lang H; Rajalingam K; Roth W; Hartmann N Cancer Genet; 2019 Oct; 238():10-17. PubMed ID: 31425920 [TBL] [Abstract][Full Text] [Related]
20. Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe. Caria P; Frau DV; Dettori T; Boi F; Lai ML; Mariotti S; Vanni R Cancer Cytopathol; 2014 May; 122(5):377-85. PubMed ID: 24510380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]